| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/20/2002 | US6437123 Triazine compounds and their use |
| 08/20/2002 | US6437120 Chemical intermediate for mirtazepine, antidepressants |
| 08/20/2002 | US6436985 Disubstituted pyrazolines and triazolines as factor Xa inhibitors |
| 08/20/2002 | US6436981 Dihydrotriazolone derivatives as pesticides |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 08/20/2002 | US6436964 Piperidine derivatives having effects on serotonin related systems |
| 08/20/2002 | US6436962 Alpha 1a adrenergic receptor antagonists; relief from benign prostatic hyperplasia by less hindered urine flow by relaxing smooth muscle tissue; with a testosterone 5-alpha reductase inhibitor, finasteride; acute and chronic relief |
| 08/20/2002 | US6436961 Substance p receptor antagonist; 2-phenyl-3-benzylaminopiperidines |
| 08/20/2002 | US6436960 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 08/20/2002 | US6436949 Heterocyclically substituted benzamides and their use |
| 08/20/2002 | US6436943 Use of dihydropyrimidines as medicaments, and novel substances |
| 08/20/2002 | US6436941 Treating schizophrenia, depression, and parkinson's disease; side effect reduction |
| 08/20/2002 | US6436939 Treatment of central nervous system disorders including sleep/wake disorders, dementia, alzheimer's disease, epilepsy, narcolepsy, eating disorders, motion sickness, vertigo |
| 08/20/2002 | US6436928 Selective neurokinin antagonists |
| 08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
| 08/20/2002 | US6436915 Antiproliferative and antitumor agents and angiogenesis inhibitors |
| 08/20/2002 | US6436904 Treatment of inflammatory diseases in mammals |
| 08/20/2002 | CA2240138C Quinazolin-4-one ampa antagonists |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062788A1 Sulfonamide compounds, their preparation and use |
| 08/15/2002 | WO2002062787A1 Pyrazoles as tgf inhibitors |
| 08/15/2002 | WO2002062786A1 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles |
| 08/15/2002 | WO2002062785A1 Benzimidazole derivatives, method for their production and use thereof as tryptase inhibitors |
| 08/15/2002 | WO2002062784A1 Piperidinee derivatives as neurokinin 1 antagonists |
| 08/15/2002 | WO2002062764A1 Fused heterocyclic compounds |
| 08/15/2002 | WO2002062763A2 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas |
| 08/15/2002 | WO2002062762A2 Potassium channel openers |
| 08/15/2002 | WO2002062755A2 Polyamide analogs as dna minor groove binders |
| 08/15/2002 | WO2002062423A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 08/15/2002 | WO2002062295A2 Pyridine-substituted benzanilides as potassium ion channel openers |
| 08/15/2002 | WO2002062290A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 08/15/2002 | WO2002040465A3 Aryloxy piperidinyl indoles for treating depression |
| 08/15/2002 | WO2002032861A3 Orally active salts with tyrosine kinase activity |
| 08/15/2002 | WO2002011724A3 Neuroprotective 2-pyridinamine compositions and related methods |
| 08/15/2002 | WO2001030768A9 Methods and compositions utilizing quinazolinones |
| 08/15/2002 | US20020111495 Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
| 08/15/2002 | US20020111494 N-type calcium channel blockers, antiischemic agents |
| 08/15/2002 | US20020111492 Bactericides |
| 08/15/2002 | US20020111461 Peptidomimetic compound for us ein the treatment of diabetes |
| 08/15/2002 | US20020111374 Estrogen receptor modulators |
| 08/15/2002 | US20020111371 Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke |
| 08/15/2002 | US20020111370 Compounds useful as antibacterial agents |
| 08/15/2002 | US20020111367 Phenyl substituted pyridine and benzene derivatives |
| 08/15/2002 | US20020111364 ABCA-1 elevating compounds |
| 08/15/2002 | US20020111358 Phenoxypropylamine compounds |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111351 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation |
| 08/15/2002 | US20020111348 Substituted oximes and hydrazones as neurokinin antagonists |
| 08/15/2002 | US20020111347 Nervous system disorders |
| 08/15/2002 | CA2437492A1 Fused heterocyclic compounds |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/15/2002 | CA2436467A1 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles |
| 08/15/2002 | CA2436461A1 Pyridine-substituted benzanilides as potassium ion channel openers |
| 08/14/2002 | EP1230249A1 Transition metal complexes with bidentate ligand having an imidazole ring |
| 08/14/2002 | EP1230248A2 Transition metal complexes attached to a polymer via a flexible chain |
| 08/14/2002 | EP1230244A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 08/14/2002 | EP1230237A1 Magnesium omeprazole |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230235A1 Compounds with antibacterial and antiparasitic properties |
| 08/14/2002 | EP1230224A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 08/14/2002 | EP1230219A1 Aromatic sulfons hydroxamic acid metalloprotease inhibitor |
| 08/14/2002 | EP1229915A1 Protease inhibitors |
| 08/14/2002 | EP1229914A1 Protease inhibitors |
| 08/14/2002 | EP1229907A1 Prevention of plaque rupture by acat inhibitors |
| 08/14/2002 | EP1087961B1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 08/14/2002 | EP0988038B1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | EP0763024B1 Processes and intermediates for the preparation of piperazine derivatives |
| 08/14/2002 | EP0754683B1 Ether compound, use thereof, and intermediate for producing the compound |
| 08/14/2002 | EP0722439B1 Hiv protease inhibitors |
| 08/14/2002 | DE10106457A1 DELTA·1·-Pyrroline DELTA · 1 · -Pyrrolines |
| 08/14/2002 | CN1364167A Endogenous constitutively activated G protein-coupled orphan receptors |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/13/2002 | US6433187 Certain polycyclic compounds useful as tubulin-binding agents |
| 08/13/2002 | US6433186 Treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants. |
| 08/13/2002 | US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/13/2002 | US6433178 3-alkyl-3-phenyl-piperidines |
| 08/13/2002 | US6433177 Reacting n-carboxyanhydride and butylamine |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6432995 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor from cells |
| 08/13/2002 | US6432988 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 08/13/2002 | US6432987 Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor action |
| 08/13/2002 | US6432981 Cyclopentyl modulators of chemokine receptor activity |
| 08/13/2002 | US6432980 Aliphatic amine substituted piperidyl diaryl pyrrole derivatives as antiprotozoal agents |
| 08/13/2002 | US6432978 4-hydroxy-1-methyl-1,2-dihydroquinolin-2-one derivatives; cardiovascular, atopic, and rheumatic disorders; antiallergens, antiinflammatory agents, antiasthmatics, and hypotensive agents |
| 08/13/2002 | US6432972 Desloratadine as non-sedating antihistamine, decongestant |
| 08/13/2002 | US6432969 Non-insulin dependent diabetes, obesity, arthritis, and osteoporosis treatment |
| 08/13/2002 | US6432963 Antiinflammatory agents; tyrosine kinase inhibitor |
| 08/13/2002 | US6432959 Antitumor agents |
| 08/13/2002 | US6432957 Piperazine derivative |
| 08/13/2002 | US6432955 Heterocyclic derivatives and their use as antithrombotic agents |
| 08/13/2002 | US6432949 Amide derivatives useful as inhibitors of the production of cytokines |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432921 Oligopeptides |
| 08/13/2002 | US6432900 Antisoilants |
| 08/13/2002 | US6432879 Substituted phenyl uracils |
| 08/13/2002 | CA2216633C Synthesis of bis-indolylmaleimides |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060893A1 Method for carbamoylating alcohols |